Pharmaceutical Contract Manufacturers in India | Industry Experts

1
Genomics and Pharmaceutical Industry a vital
partnership for treatment and control of
diseases. Genomics, the study of genes, is
considered to be the most transformative
technology of the 21st century. Genomics has
scientifically proven abilities in the
prevention, management and treatment of diseases
and has emerged as a useful and effective way to
diagnose serious diseases like cancer, ancestry
genetic diseases, etc., For example, genome
sequencing helps in detecting the cancer in its
early stage and helps the clinicians to provide
proper oncology treatments for
patients. COVID-19 has positively impacted the
genomics market as the researchers have gained a
better understanding of the coronavirus because
of the innovative genome technologies with
senior scientists and researchers confirming that
genome sequencing has revealed that the omicron
variant shows a lot of mutation in its spike
protein, unlike the delta variant.
Advanced genomics techniques have made the
process of sequencing a lot easier and today, a
human genome can be sequenced within 24 hours and
consumers can purchase a DNA sequence that can
reveal their ethnic lineage going back
generations. Valued at USD 20.1 billion in 2020
the global market of the genomics industry was
expected to grow at a CAGR of 15.35 from 2021 to
2028. The top global genomics company like
Illumina, Genomic Health, Bluebird Bio, CRSPR
Therapeutics have helped in expanding the
availability, accessibility and quality of
genomic-based health services. It is expected
that the next few years will reveal more human
genomic information which will help in enabling
new therapeutic and preventive options to treat
human diseases. Talking about the Indian genomics
industry, the India oncology next-generation
sequencing (NGS) market size was valued at USD
16.87 million in 2020 and is
2
expected to grow at a CAGR of 19.6 from 2021 to
2028. Medgenome, Redcliffe life sciences, Lilac
Insights, The Gene Lab are the top Indian gene
testing companies which are using properly
advanced technologies and are continuously
working towards the improvement of patient care
and disease management. Initiatives taken by the
government to build a genomic database for the
Indian population and an exponential decline in
the costs of genetic sequencing has driven the
market growth and according to the professionals,
India holds great potential in genomics as the
market is continuously rising. The Genome India
Project, initiated by the department of
Biotechnology in 2020, intended to collect
10,000 samples of Indian citizens to build
reference genome. Very recently, the Government
of India has identified genomics as a thrust
sector and have announced several schemes with
participatory funding from the Government. Such
initiatives are expected to increase the usage of
genomic products, which will drive the growth of
the Indian Genomics industry. The essential
genetic developments and their applications in
various areas like bioengineering, synthetic
biology, epistasis, intragenomic phenomena etc.
have resulted in the massive growth of the
genomics market. The participation of the
pharmaceutical industry in such research shall
result in the development of advanced drugs and
medicines and thereby contract manufacture. India
is known as the Pharmacy of the World and thus
stands in a unique position for contract
manufacture. The contract manufacture under
license of the Astrazeneca and other vaccines
for Covid 19 for both domestic consumption and
vital exports including supplies to the WHO, is
a case in point with regard to contract
pharmaceutical manufacturers in India.
3
(No Transcript)